Australian Arthritis Biobank

Registration Status: Pending
Objective:

To identify causes and predict prognosis and treatment response for arthritis To develop a biobank of blood, cells, synovial fluid, urine, faecal material, synovial tissue, bone, cartilage, tendon muscle and skin initially from people with inflammatory arthritis including rheumatoid arthritis, psoriatic arthritis, juvenile arthritis and ultimately for people with osteoarthritis and osteoporosis and a range of connective tissue disorders.

Registered Biobank Name Australian Arthritis Biobank (AABB)
Biobank Leader Lyn March
Principal Investigator Prof Lyn March ; Prof Chris Jackson
Address Department of Rheumatology, Royal North Shore Hospital
St Leonards, NSW, Australia
Website
Email for biobank inquiries lyn.march@sydney.edu.au
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: